HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

C Patrick Reynolds Selected Research

Neuroblastoma

10/2015Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
5/2015Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.
3/2015Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression.
12/2014Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.
1/2014Initial testing (stage 1) of the Polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program.
1/2014Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.
11/2013Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
11/2013Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program.
9/2013Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
4/2013Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


C Patrick Reynolds Research Topics

Disease

88Neoplasms (Cancer)
11/2015 - 12/2002
52Neuroblastoma
10/2015 - 06/2002
20Sarcoma (Soft Tissue Sarcoma)
11/2015 - 07/2006
18Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2015 - 09/2007
17Leukemia
05/2015 - 06/2007
13Rhabdomyosarcoma
03/2015 - 06/2008
11Osteosarcoma (Osteogenic Sarcoma)
08/2013 - 03/2008
8Wilms Tumor (Wilm's Tumor)
11/2014 - 05/2008
8Glioblastoma (Glioblastoma Multiforme)
02/2014 - 03/2008
8Anoxia (Hypoxia)
09/2011 - 04/2003
6Ewing's Sarcoma (Sarcoma, Ewing)
03/2015 - 08/2004
6Rhabdoid Tumor (Rhabdoid Tumors)
07/2010 - 05/2008
5Neoplasm Metastasis (Metastasis)
09/2013 - 06/2003
4Residual Neoplasm
12/2014 - 08/2004
4Medulloblastoma
04/2013 - 03/2008
3Alveolar Rhabdomyosarcoma
04/2013 - 07/2008
3Pain (Aches)
11/2010 - 01/2009
3Brain Neoplasms (Brain Tumor)
07/2009 - 06/2002
2Necrosis
10/2015 - 01/2014
2Hypotension (Low Blood Pressure)
11/2010 - 03/2006
2Hypersensitivity (Allergy)
11/2010 - 09/2010
2Carcinoma (Carcinomatosis)
07/2009 - 06/2008
1Sudden Infant Death (SID)
11/2014
1Cholestasis
01/2014
1Fever (Fevers)
01/2014
1Bacteremia
01/2014
1Drug Toxicity (Drug Safety)
01/2014

Drug/Important Bio-Agent (IBA)

36N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA
11/2015 - 12/2007
15FenretinideIBA
01/2014 - 07/2003
7Vincristine (Oncovin)FDA LinkGeneric
11/2015 - 07/2007
7Melphalan (Alkeran)FDA LinkGeneric
10/2015 - 09/2003
7Isotretinoin (Accutane)FDA LinkGeneric
12/2014 - 06/2004
6DNA (Deoxyribonucleic Acid)IBA
03/2015 - 09/2010
6ABT-737IBA
10/2014 - 09/2007
6Topotecan (Hycamtin)FDA LinkGeneric
11/2013 - 10/2007
6CytotoxinsIBA
12/2010 - 04/2004
5Proteins (Proteins, Gene)IBA
11/2011 - 09/2007
5Etoposide (VP 16)FDA LinkGeneric
02/2011 - 09/2003
4Messenger RNA (mRNA)IBA
03/2015 - 07/2007
4RNA (Ribonucleic Acid)IBA
12/2010 - 08/2004
4AgarIBA
06/2007 - 01/2005
3Buthionine SulfoximineIBA
10/2015 - 04/2003
3temozolomide (Temodar)FDA LinkGeneric
02/2015 - 03/2009
3Phosphotransferases (Kinase)IBA
05/2013 - 06/2008
3Sirolimus (Rapamycin)FDA Link
02/2011 - 04/2008
3Cisplatin (Platino)FDA LinkGeneric
12/2010 - 01/2008
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2010 - 09/2003
3Interleukin-2 (IL2)IBA
11/2010 - 03/2006
3Carboplatin (JM8)FDA LinkGeneric
07/2007 - 09/2003
3Trypan BlueFDA Link
06/2007 - 01/2005
2OxygenIBA
05/2015 - 01/2005
2irinotecan (Camptosar)FDA LinkGeneric
03/2015 - 03/2009
23-Iodobenzylguanidine (Iobenguane)IBA
09/2013 - 06/2004
2Surface Antigens (Surface Antigen)IBA
09/2013 - 09/2003
2PlasticsIBA
04/2012 - 04/2007
2Asparaginase (Elspar)FDA Link
01/2012 - 09/2007
2Drug CombinationsIBA
11/2011 - 09/2009
2MLN 8237IBA
11/2011 - 07/2010
2Dopamine (Intropin)FDA LinkGeneric
11/2010 - 03/2006
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2010 - 06/2002
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2010 - 09/2007
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2009 - 04/2007
2Histone Deacetylase InhibitorsIBA
09/2009 - 07/2007
2Antineoplastic Agents (Antineoplastics)IBA
02/2009 - 01/2005
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2007 - 10/2007
2tirapazamine (SR 4233)IBA
04/2005 - 04/2003
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2004 - 06/2004
1TaxoidsIBA
11/2015
14- acetoxy- 13- ((3- ((tert- butoxycarbonyl)amino)- 2- hydroxy- 3- phenylpropanoyl)oxy)- 1- hydroxy- 7,10- dimethoxy- 9- oxo- 5,20- epoxytax- 11- en- 2- yl benzoateFDA Link
11/2015
1docetaxel (Taxotere)FDA Link
11/2015
1Glutathione (Reduced Glutathione)IBA
10/2015
1Cephalosporins (Cephalosporin Antibiotics)IBA
10/2015
1AntigensIBA
05/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2015
14-oxoretinoic acidIBA
12/2014
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
12/2014
1Angiogenesis InhibitorsIBA
11/2014
1AZD1480IBA
11/2014
1Janus KinasesIBA
11/2014
1Adenosine Triphosphate (ATP)IBA
11/2014
12- (5,7- difluoro- 1,2,3,4- tetrahydronaphthalen- 3- ylamino)- N- (1- (2- methyl- 1- (neopentylamino)propan- 2- yl)- 1H- imidazol- 4- yl)pentanamideIBA
08/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
08/2014
1pixantrone (BBR 2778)IBA
05/2014
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2014
1polo-like kinase 1IBA
01/2014
1HemosiderinIBA
01/2014
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2014
1BI 6727IBA
01/2014
1Monoclonal AntibodiesIBA
09/2013
1samarium cobaltIBA
09/2013
12- (3- amino- 2- hydroxypropyl)hexacosahydro- 3- methoxy- 26- methyl- 20,27- bis(methylene)11,15- 18,21- 24,28- triepoxy- 7,9- ethano- 12,15- methano- 9H,15H- furo(3,2- i)furo(2',3'- 5,6)pyrano(4,3- b)(1,4)dioxacyclopentacosin- 5- (4H)- oneIBA
08/2013
1Antimitotic AgentsIBA
08/2013

Therapy/Procedure

67Heterologous Transplantation (Xenotransplantation)
11/2015 - 12/2002
13Drug Therapy (Chemotherapy)
09/2013 - 06/2002
3Stem Cell Transplantation
09/2013 - 01/2006
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2013 - 07/2003
2Radiotherapy
05/2013 - 01/2013
2Withholding Treatment
07/2008 - 06/2008
2Transplants (Transplant)
07/2006 - 06/2006
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
09/2013